SE8002715L - Injicerbara lekemedel med inflammationshemmande verkan samt sett for framstellning derav - Google Patents

Injicerbara lekemedel med inflammationshemmande verkan samt sett for framstellning derav

Info

Publication number
SE8002715L
SE8002715L SE8002715A SE8002715A SE8002715L SE 8002715 L SE8002715 L SE 8002715L SE 8002715 A SE8002715 A SE 8002715A SE 8002715 A SE8002715 A SE 8002715A SE 8002715 L SE8002715 L SE 8002715L
Authority
SE
Sweden
Prior art keywords
inflammation
preparation
medicinal products
injectable medicinal
disability
Prior art date
Application number
SE8002715A
Other languages
Unknown language ( )
English (en)
Other versions
SE451428B (sv
Inventor
M Ghyczy
G Ritzmann
A Erdos
E Etschenberg
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of SE8002715L publication Critical patent/SE8002715L/sv
Publication of SE451428B publication Critical patent/SE451428B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8002715A 1979-04-11 1980-04-10 Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losning SE451428B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792914789 DE2914789A1 (de) 1979-04-11 1979-04-11 Injizierbare arzneimittel mit entzuendungshemmender wirkung

Publications (2)

Publication Number Publication Date
SE8002715L true SE8002715L (sv) 1980-10-12
SE451428B SE451428B (sv) 1987-10-12

Family

ID=6068138

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002715A SE451428B (sv) 1979-04-11 1980-04-10 Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losning

Country Status (14)

Country Link
US (1) US4309420A (sv)
JP (1) JPS55147217A (sv)
AT (1) AT369650B (sv)
AU (1) AU539043B2 (sv)
BE (1) BE882732A (sv)
CA (1) CA1136048A (sv)
CH (1) CH642547A5 (sv)
DE (1) DE2914789A1 (sv)
FR (1) FR2453646A1 (sv)
GB (1) GB2047535B (sv)
IT (1) IT1148791B (sv)
NL (1) NL8002096A (sv)
SE (1) SE451428B (sv)
ZA (1) ZA802158B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042365A1 (de) * 1980-11-10 1982-06-03 Harsanyi, Dr., Eugen, 5014 Kerpen Fluessige lecithin-haltige einphasige mehrstoffsysteme
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
US5196567A (en) * 1983-02-19 1993-03-23 Kaken Pharmaceutical Co., Ltd. Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
ATE218872T1 (de) * 1995-01-27 2002-06-15 Univ Texas Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
KR102162901B1 (ko) 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
AU2021244695A1 (en) 2020-03-26 2022-11-10 Plx Opco Inc. Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
GB1214515A (en) * 1967-04-11 1970-12-02 Sumitomi Chemical Company Ltd Indole derivatives and salts thereof
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4093733A (en) * 1976-09-09 1978-06-06 Merck & Co., Inc. Parenteral suspensions
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Also Published As

Publication number Publication date
JPH0210805B2 (sv) 1990-03-09
BE882732A (fr) 1980-07-31
GB2047535A (en) 1980-12-03
DE2914789A1 (de) 1980-10-16
NL8002096A (nl) 1980-10-14
AU539043B2 (en) 1984-09-06
FR2453646A1 (fr) 1980-11-07
JPS55147217A (en) 1980-11-17
US4309420A (en) 1982-01-05
ATA194780A (de) 1982-06-15
DE2914789C2 (sv) 1991-05-29
IT8021300A0 (it) 1980-04-10
AT369650B (de) 1983-01-25
FR2453646B1 (sv) 1985-01-25
IT1148791B (it) 1986-12-03
CA1136048A (en) 1982-11-23
CH642547A5 (de) 1984-04-30
SE451428B (sv) 1987-10-12
GB2047535B (en) 1983-10-26
AU5733080A (en) 1980-10-16
ZA802158B (en) 1981-05-27

Similar Documents

Publication Publication Date Title
SE8002714L (sv) Parenteralt applicerbara, stabila lekemedelslosningar med inflammationshemmande verkan samt sett for framstellning derav
SE8002715L (sv) Injicerbara lekemedel med inflammationshemmande verkan samt sett for framstellning derav
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
SE7910371L (sv) Oralt intagbart lekemedel med inflammationshemmande verkan
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
NL930044I2 (nl) ImidazoÄ1,2-aÜ pyridinederivaten, de bereiding hiervan en de therapeutische toepassing.
NO174412C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse
FI103180B (sv) Framställning av läkemedel innehållande flurbiprofen för bekämpning av smärtor och/eller inflammationer hos djur och människor
MX171191B (es) Composiciones farmaceuticas de glipizida
SE7413548L (sv)
NL7803247A (nl) Preparaat ter bestrijding van ontsteking.
FR2674754B1 (fr) Composition medicamenteuse micronisee.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
AU3668584A (en) Pharmaceutical preparations containing a phospholipidan an oxicam derivative
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ES2078256T3 (es) Formula farmaceutica para uso topico que contiene diclofenaco sodico.
NO801759L (no) Farmasoeytisk tilberedning for oral administrasjon samt fremgangsmaate for fremstilling av tilberedningen
IT1143921B (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
GB1547562A (en) Guns eg for use in the administration of drugs or medicines to animals
DE3689254T2 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
FR2236488A1 (sv)
BE863843A (fr) Nouveaux derives d'acides benzo-heterocyclylglyoxyliques, leur preparation et leur application en tant que medicaments
FI863192A (fi) Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002715-4

Effective date: 19931110

Format of ref document f/p: F